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ABSTRACT
Etiology of human breast cancer is unknown, whereas the Mouse Mammary Tumor 
Virus (MMTV) is recognized as the etiologic agent of mouse mammary carcinoma. 
Moreover, this experimental model contributed substantially to our understanding 
of many biological aspects of the human disease. Several data strongly suggest a 
causative role of MMTV in humans, such as the presence of viral sequences in a 
high percentage of infiltrating breast carcinoma and in its preinvasive lesions, the 
production of viral particles in primary cultures of breast cancer, the ability of the 
virus to infect cells in culture. This paper demonstrates that MMTV is present in 
human saliva and salivary glands. MMTV presence was investigated by fluorescent 
PCR, RT-PCR, FISH, immunohistochemistry, and whole transcriptome analysis. Saliva 
was obtained from newborns, children, adults, and breast cancer patients. The saliva 
of newborns is MMTV-free, whereas MMTV is present in saliva of children (26.66%), 
healthy adults (10.60%), and breast cancer patients (57.14% as DNA and 33.9% as 
RNA). MMTV is also present in 8.10% of salivary glands. RNA-seq analysis performed 
on saliva of a breast cancer patient demonstrates a high expression of MMTV RNA in 
comparison to negative controls. The possibility of a contamination by murine DNA 
was excluded by murine mtDNA and IAP LTR PCR. These findings confirm the presence 
of MMTV in humans, strongly suggest saliva as route in inter-human infection, and 
support the hypothesis of a viral origin for human breast carcinoma.
INTRODUCTION
The etiology of human breast carcinoma is 
unknown, with the exception of hereditary tumors, where 
inherited gene mutations are able to confer a high risk 
of developing cancer, and of radiation induced tumors. 
Estrogens are well known as relevant pathogenetic factors, 
but a transforming role could never be shown for them [1].
On the other hand, the Mouse Mammary Tumor 
Virus (MMTV) has been demonstrated as the causative 
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agent of tumors of the mammary gland in mouse [2, 3]. 
In this context, attention needs to be focused on the fact 
that the MMTV model of breast carcinoma taught us much 
of what is known about the pathogenesis of the human 
sporadic breast carcinoma (HSBC) [4], in particular the 
concepts of cancer progression, preinvasive lesions, and 
promotional role of estrogens.
The quest for a possible viral etiology of HSBC was 
unsuccessful until 1995, when the laboratory of Beatriz 
Pogo selected a 660-bp region of MMTV with a nucleotide 
sequence identity of only 16% to human endogenous 
retroviral element K10, which is highly similar to MMTV, 
and 90% to 98% identical to the MMTV envelope (env) 
gene [5]. Moreover, the same authors, by using MMTV-
specific primers located in the 660-bp region, identified a 
MMTV env gene–like exogenous sequence (MMTVels) in 
38–40% of infiltrating HSBC.
These data were confirmed by several different 
groups, but negative results were also published. In 
2006 we were able to design a rigorous methodological 
approach able to overcome any possible difficulty, and 
to definitively demonstrate that MMTV sequences are 
present in infiltrative HSBC in a percentage between 30% 
and 40% [6].
In the meantime, the isolation of viral particles from 
primary cultures of human breast cancer cells [7], the 
demonstration that MMTV can infect human cells [8], and 
the discovery of the viral origin of cervical carcinoma by 
HPV [9] gave more attention to the possibility that a virus 
could be involved in the initiation of HSBC.
In 2011 [10], we showed the presence of MMTVels 
in the different phases of HSBC progression, from normal 
gland tissue to infiltrative carcinoma via atypical epithelial 
hyperplasia and ductal carcinoma in situ (DCIS). At the 
same time, by real-time quantitative PCR we showed 
that a different viral load correlated with the stage of 
tumor progression. Moreover, by chromogenic in situ 
hybridization (CISH) we obtained very clear signals 
indicating the nuclear presence of MMTVels.
Recently, two interesting papers showed the 
presence of MMTV in human milk and in human milk 
cells [11, 12].
Surprisingly, in a recent study searching for known 
and novel viruses in human tumors, massive sequencing 
was not able to individuate MMTV [13], but a careful 
reading of the complete analysis (http://larssonlab.org/
tcga-viruses/report_BRCA.php) shows the presence of a 
low MMTV expression in some breast cancer samples.
All considered, the amount of information available 
today strongly supports the hypothesis that MMTV plays 
a causative role in HSBC. However, how the virus could 
infect humans still remains an open question.
Once more, the murine MMTV model was of 
help: in mice MMTV is expressed also in salivary glands 
[14]. As saliva is a common route of spreading of viral 
infections, we decided to investigate human salivary 
glands and saliva and we were successful in demonstrating 
in both of them the presence of MMTV.
RESULTS
MMTV sequences are present in human saliva, 
with the exception of newborns
Saliva samples were collected at the Pisa University 
Hospital from a total of 235 consecutive individuals, 
grouped as follows: 56 breast cancer female patients, 132 
healthy adult blood donors of both genders, 30 pediatric 
patients of both genders, 17 newborns of both genders 
(Table 1). Samples were collected anonymously according 
to the rules of the Ethics Committee of the Pisa University 
Hospital.
MMTV DNA was present in 26.66% (8/30 cases) of 
children, with 25% of females (5/20), and 30% of males 
(3/10). In adults, 10.6% resulted positive (14/132), with 
15% of females (12/78) and 3.7% of males (2/54).
For what concerns breast cancer patients, MMTV 
DNA was present in 57.14% of cases (32/56), whereas 
MMTV RNA was present in 33.9% of cases (19/56). 
A simultaneous presence of viral DNA and RNA 
occurred in 23.21% of cases (13/56). On the other 
hand, a combination DNA positive/RNA negative was 
found in 33.92% of cases (19/56) and a combination 
DNA negative/RNA positive was present in 10.71% of 
cases (6/56).
The fact that saliva of newborns was free of MMTV 
DNA in all cases needs to be stressed.
A whole transcriptome analysis of MMTV 
confirms the presence of viral RNA in saliva
RNA-seq analysis performed on a DNA MMTVels 
positive saliva from a breast cancer patient and on 
two DNA MMTVels negative normal breast tissues 
demonstrated the presence of RNA MMTV in the saliva 
with an expression value of 0.26 FPKM, whereas it was 
of 0.00 FPKM and 0.04 FPKM in the two breast tissue 
samples used as negative controls (Figure 1).
FISH shows a cytoplasmic positivity in 
saliva cells
FISH analysis on MMTVels positive saliva 
demonstrated a cytoplasmic positivity in rare cells 
with morphology compatible with exfoliated epithelial 
cells (Figure 2). The p53 probe used as internal control 
hybridized inside the nucleus, as expected. The MMTV 
probe used is too short to reveal possible genome 
integration sites in the nucleus. On the other hand, the fact 
that it can bind also RNA well explains the presence of 
cytoplasmic signals.
Oncotarget18357www.impactjournals.com/oncotarget
MMTV sequences are present in human salivary 
glands with a frequency similar to that of the 
saliva of the adult general population
Thirty-seven formalin fixed and paraffin embedded 
blocks (FFPE) of normal salivary gland tissue, from the 
same number of individuals, were obtained from the files 
of the Department of Pathology of the Pisa University 
Hospital and of the “San Rossore” Hospital in Pisa.
MMTVels DNA was present in 8.1% of cases 
(3/37), with 5% of females (1/20) and 11.7% of males 
(2/17) (Table 1). As said before, the saliva of the adult 
general population is positive for MMTV in 10.6% 
of cases.
Figure 1: Whole transcriptome analysis of human saliva. Reads count mapped to MMTV genome. A. MMTVels positive sample 
for a breast cancer patient. B and C. MMTVels negative human breast tissues used as negative control. A strong difference between A and 
B/C is easily evident.
Table 1: Presence of MMTVels in human saliva and salivary glands







DNA + / 
RNA+
DNA + / 
RNA −
DNA − / 
RNA +
n % n % n % n % n %
a) newborns 17 0 0
b) children 30 8 26.66
c) adult healthy donors 132 14 10.60
d) breast cancer patients 56 32 57.14 19 33.9 13 23.21 19 33.92 6 10.71
a+b+c+d 235 54 22.97
b+c+d 218 54 24.77
c+d 188 46 24.46







n % n %
37 3 8.10 34 91.9
a) Saliva: MMTV DNA is absent in newborns; in children it is present in a percentage more than double than in healthy 
adults; in breast cancer patients the percentage of positivity is five time that in healthy adults. MMTV RNA is present in one 
third of breast cancer patients. Discrepancy in percentage of positivity between MMTV DNA and RNA can be consequence 
of a different MMTV status, in active replication or in latency. b) Salivary glands: MMTVels are present in a percentage 
(8.10%) very similar to that of healthy adults with positive saliva (10.60%)
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Salivary glands contain the MMTV-p14 protein
MMTV-p14 is the signal peptide of the MMTV 
envelope precursor, localized in the nucleolus of cells 
harboring the virus and with nucleo-cytoplasmic 
shuttling [15]. p14 expression was analyzed by 
immunohistochemistry in the two groups of salivary 
glands resulted positive and negative for MMTVels DNA 
respectively. All three MMTVels positive glands showed a 
cytoplasmic positivity for p14, whereas MMTVels negative 
cases resulted negative (Figure 3). In a few nucleoli of the 
positive samples a faint staining was also observed.
Saliva samples are not contaminated by 
mouse DNA
A possible mouse DNA contamination of MMTVels 
positive saliva samples was excluded by performing 
murine mitochondrial DNA (mtDNA) and Intracisternal 
A Particle (IAP) LTRs PCR. All tested samples resulted 
free of mouse DNA (Figure 4).
DISCUSSION
In mouse, MMTV is transmitted from the mother to 
the offspring by milk [2]. Milk contains a high quantity 
of viral particles [16], most of which are destroyed by 
gastric juice [17]. In the ileum, at the Peyer’s patches, 
particles enter into the newborn-type epithelial cells and 
M cells by a process of endocytosis [18]. The interaction 
between MMTV Env protein and Toll-like receptor 4 
allows the infection of B cells, that present Sag (Super 
Antigen) to CD4+ T cells. These activated T cells stimulate 
and recruit other B and T cells, with the result of a further 
activation of immune cells and of the amplification of a 
reservoir of MMTV infected cells. Finally, B cells reach 
the mammary gland, where they are able to spread the 
infection to epithelial cells. These data [14, 19] make 
clear that, differently from other types of viruses, in 
the case of MMTV the presence of lymphoid structures 
at the entrance site and a working immune system are 
indispensable prerequisites for infection.
In mouse, MMTV is the causative agent of 
mammary tumors. Moreover, this experimental model 
was of great relevance for the understanding of many of 
the biological and morphological characteristics of human 
breast cancer [4].
Notwithstanding the strong similarities between 
mouse and human tumors, the efforts to demonstrate 
a viral origin for HSBC were unsuccessful. However, 
nowadays there is a substantial amount of data supporting 
this possibility, such as: the presence of MMTV sequences 
Figure 2: FISH analysis of MMTVels in human saliva. MMTV signals in the cytoplasm of a possible epithelial exfoliated cell. In 
the nucleus a positive p53 signal is evident as control.
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Figure 3: Immunohistochemical analysis of p14 protein expression in human salivary glands. A. a cytoplasmic positivity 
for p14 is well evident in a sample positive for MMTVels. B. higher magnification of A; C. absence of p14 in a sample negative for 
MMTVels.
Figure 4: Murine mitochondrial DNA and Intracisternal A Particles long terminal repeats (IAP LTRs) PCR in human 
saliva. A) mtDNA: MMTVels positive saliva samples (lanes 1–12); A and C. are PCR and nested PCR negative controls; B. is mouse 
DNA. All human samples result negative. B) IAP LTRs: MMTVels positive saliva samples (lanes 1–12); D. is a PCR negative control; 
E. is mouse DNA. All human samples result negative.
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in a percentage between 30% and 40% of infiltrating 
HSBC [5, 6]; the presence of MMTV sequences shown by 
CISH in the nucleus of tumor cells [10]; the demonstration 
of a strict relationship between the presence of MMTV 
sequence and the progression of HSBC (normal gland, 
atypical ductal epithelial hyperplasia, ductal carcinoma 
in situ) [10]; the production of viral particles in primary 
cultures of human breast cancer [7]; the ability of MMTV 
to infect human cells in culture [8, 20]; the identification 
of a molecular mechanism that facilitates entrance of 
MMTV in non-murine cells [21].
The viral hypothesis for HSBC would receive a 
strong support if a route of infection could be defined for 
humans. Unfortunately, there are biological reasons that 
make milk improbable as vehicle in MMTV transmission 
in humans. In fact, in mouse a critical number of intact 
viral particles is necessary for the infection and this 
is obtained by a long period of breastfeeding, in that at 
any lactation the largest part of virus is destroyed in the 
stomach [17, 18, 22]. On the other hand, viral particles 
have been demonstrated in human milk [23], but in a very 
low concentration [24], and human milk has been shown 
to exert a destructive action on MMTV particles [24, 
25]. Moreover, since a long time in humans lactation is 
considered protective against breast cancer or ineffective 
[26]. However, the presence of traces of MMTV in human 
milk, in terms of viral particles and sequences [11, 12], 
well supports the possibility of a human MTV.
Very few papers analyzed, unsuccessfully, the 
possibility of a zoonotic MMTV infection of humans, 
directly from mouse or by an intermediate host, such as a 
dog or a cat [27–30].
Abandoning the idea of human milk as a route for 
MMTV transmission, we went back once more to the 
mouse model, where we found that MMTV particles are 
produced in salivary glands too [14]. Moreover, saliva is a 
very common route of inter-human transmission for viral 
infections.
Our results (Tables 1) demonstrate that MMTV 
DNA is present in saliva and in salivary glands of healthy 
adults in a very similar percentage (10.6% and 8.1% 
respectively). At the same time, the percentage of positive 
cases in pediatric age is almost three times higher; these 
data are not surprising, considering that kids are much 
more prone than adults to infections, mainly viral. Very 
interestingly, positive cases go up to almost 60% in HSBC 
patients. Discrepancies in percentage of positivity found 
for MMTV DNA and RNA and for the combination of 
both can be consequence of a different MMTV status, in 
active replication or in latency.
Finally, the absence of MMTVels in the saliva of 
newborns eliminates the possibility of a trans-placental 
route and strongly supports the possibility of an inter-
human transmission of MMTV.
This study for the first time reports a whole 
transcriptome analysis of MMTV sequences in a human 
sample, showing a much higher presence of RNA MMTV 
reads in the saliva of a breast cancer patient compared to 
tissues obtained from non-cancer breasts used as negative 
controls (Fig. 1).
As molecular morphological approach, we used 
FISH analysis on saliva resulted positive for both DNA 
and RNA MMTVels by fluorescent nested PCR (Fig. 2). 
Few clear signals are evident in the cytoplasm of cells that 
morphologically look like epithelial exfoliated cells. The 
probe used is capable of hybridizing also RNA sequences, 
suggesting the presence of viral particles in the cytoplasm. 
This approach was used only once in the past, showing 
signals in different chromosomes in primary cultures of 
metastatic breast cancer cell lines established from pleural 
effusions of patients [31].
Finally, the immunohistochemical analysis of 
salivary gland tissue showed, according to previous data 
[15], a clear cytoplasmic positivity for the MMTV protein 
p14 in PCR positive cases, whereas the absence of the 
same protein was documented in PCR negative cases.
An experimental paper at the end of 90′ [32] 
demonstrates that adult mice can be infected by MMTV 
through nasal inoculation of infected milk; in fact, viral 
particles are able to cross the respiratory epithelium 
and to initiate their infectious cycle in the lymphoid 
tissue associated to nasal mucosa (NALT). This paper 
shows two highly relevant facts: 1) MMTV can infect 
adult animals, 2) the site of entrance of MMTV can be 
different from the small intestine, provided the presence 
of a mucosa and of a mucosa associated lymphoid tissue, 
where the virus can be amplified before spreading to 
exocrine glands. This report strongly supports our finding, 
suggesting that in humans MMTV, spread by saliva, can 
reach the nasopharyngeal mucosa associated lymphoid 
tissue and the lymphatic structures of the Waldeyer’s ring, 
where it can be amplified and from where it can spread to 
other sites, breast included.
The available data also suggests that the presence 
of MMTV in humans is not consequence of a zoonosis, 
but of a cross-species transmission taken place in ancient 
times, with a consequent inter-human transmission by 
saliva. A similar event has already been demonstrated for 
HIV, from chimpanzees to humans [33].
This hypothesis is well supported by a very recent 
paper [34] reporting a frequent presence of human beta 
retrovirus (HBRV) infection at the site of disease in 
patients with primary biliary cirrhosis and in biliary 
epithelium of patients with autoimmune hepatitis and 
cryptogenic liver disease. HBRV is a new name that 
authors give to MMTV.
Finally, in recent years data about the role of XMRV 
in human prostate cancer were questioned on the basis 
of a possible contamination by murine material. This 
occurrence was excluded in our study by showing the 
absence of mouse mitochondrial DNA and of intracisternal 
A particle LTR, as suggested [35].
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This paper strongly supports a viral etiology for 
HSBC offering a possible route of infection. However, 
additional studies are necessary to demonstrate the 
molecular mechanism of the process. If this hypothesis 
is proven, the possibility for human breast cancer of 




Thirty-seven formalin fixed and paraffin embedded 
blocks (FFPE) of normal salivary gland tissue, from the 
same number of individuals, were obtained from the files 
of the Department of Pathology of the Pisa University 
Hospital and of the “San Rossore” private Hospital in Pisa. 
The patients were 17 males and 20 females, with a mean 
age of 54 years (with the exception of a 6 months old girl). 
Parotid was resected in 35 cases and a minor salivary gland 
in 2 cases. Surgery was due to a benign primary tumor of 
salivary glands in 19 cases, to a malignant primary tumor 
of salivary glands in 2 cases, to a non neoplastic lesion 
of the salivary glands in 8 cases, to a malignant tumor of 
the contiguous tissues (skin, subcutaneous tissue, lymph 
nodes) in 4 cases, to a benign pathology of the contiguous 
tissues in 3 cases, to a thrombosis of a intra-parotid blood 
vessel in one case. All blocks were made anonymous prior 
to the laboratory procedures, according to the rules of the 
Ethics Committee of the Pisa University Hospital.
Laser Microdissection
Salivary gland tissues were laser microdissected 
(Leica Microsystems, Wetzlar, Germany). Sections 2 μm 
thick were cut from each case using a new microtome 
blade for each slide, obtaining a total of 10,000 to 15,000 
cells. Stromal and inflammatory cells were carefully 
excluded.
Saliva
Saliva samples were collected anonymously at the 
Pisa University Hospital from a total of 235 consecutive 
individuals, grouped as follows: 56 breast cancer female 
patients, 132 healthy adult blood donors of both genders, 
30 pediatric patients of both genders, 17 newborns of 
both genders. In newborns oral swabs were used (DNA 
Genotex, Ontario, Canada). For all others subjects, 3 ml 
of saliva were collected in 50ml empty tubes and treated 
within 2 hours for DNA and RNA isolation.
DNA isolation
Saliva samples: DNA isolation was performed 
using Genomic DNA from Tissue kit (Macherey-Nagel, 
Duren, DE), following the manufacturer’s protocol at the 
section “DNA extraction from clinical samples”.
Salivary tissues: samples were incubated overnight 
at 37°C in a home-made lysis buffer containing 10 mM 
Tris-HCl, 1 mM ethylenediamine tetraacetic acid (EDTA), 
1% Tween 20, and 0.1 mg/ml proteinase K (Qiagen, Venlo, 
Netherlands). Afterwards the samples were processed for 
DNA amplification.
RNA isolation and RT-PCR
RNA extraction from saliva samples was performed 
using the QIAamp viral RNA mini kit (Qiagen, Venlo, 
Netherlands) according to manufacturer’s protocol. RNA 
was reverse transcribed in a final volume of 20 μl, using 
the kit from Invitrogen.
MMTVels detection: PCR
Fluorescence-nested PCR was used to detect 
the presence of the DNA and RNA MMTV env-like 
sequence. The pairs of primer were designed on the basis 
of the sequence available in GenBank (accession number 
AF243039). The protocol used has previously been 
described [10].
Research of mouse DNA
The presence of contaminating mouse DNA was 
analyzed by performing murine mitochondrial DNA and 
IAP LTRs PCR, according to Robinson et al [35].
FISH analysis
Two ml of a saliva sample positive at MMTVels 
PCR detection was collected in a ThinPrep PreservCyt 
Solution (Hologic, Inc., Bedford, MA, USA), and plated 
on glass slides as a monolayer using the ThinPrep 2000 
System (CYTYC Corporation Marlborough, MA, USA).
The HMTV FISH probe was prepared in-house 
by amplification of a 2.7-kb PCR product using primers 
previously described [31]. FISH experiments were 
performed using the Cytology FISH kit (Dako, Glostrup, 
Denmark).
Immunohistochemistry
Immunohistochemical assay was performed on 
5 μm-thick paraffin sections. The antigen retrieval 
was achieved with MS-unmasker solution (DIAPATH, 
Martinengo, BG, Italy) in microwave. Histostain–Plus kit 
(Invitrogen, Carlsbad, CA, USA) was used according to 
manufacturer’s protocol.
The slides were incubated with a primary antibody, 
rabbit polyclonal anti-MMTV-p14 (1:500 dilution), 
then developed with diaminobenzidine chromogen 
(DAB) (DAKO, Glostrup, DK) and counterstained with 
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hematoxylin. Negative control included the omission of 
the primary antibody.
Whole transcriptome analysis (RNA-seq)
Library and template preparation: RNA-seq was 
performed using Ion ProtonTM Sequencer (Ion Torrent, 
Life Technologies, Grand Island, NY). The starting 
material of 500 ng of total RNA was treated with the 
Low Input RiboMinus Eukaryote Kit v2 (Ambion, Life 
Technologies, Grand Island, NY) to remove rRNA species. 
The manufacturer’s protocols were followed for cDNA 
and template production. 165 millions wells Proton™ 
I Chip were used for sequencing.
Mapping of RNA-Seq reads using TopHat 2 
and Bowtie: Bioinformatics analysis was carried out 
using several command line software included in 
Bio-Linux (http://nebc.nerc.ac.uk/tools/bio-linux/bio-
linux-7-info). Using TopHat2 the reads, previously filtered 
for the quality and length, were processed and aligned to 
a reference sequence obtained by concatenating the H. 
sapiens reference genome (build hg19) and MMTV virus 
sequence (NC_001503), using as reference annotation a 
custom gtf annotation file. This file was built by joining 
the Genomes UCSC hg19 annotation file and MMTV 
annotations. The unmapped reads, generated from the first 
step, were re-aligned by using Bowtie2. The reads mapped 
with Tophat2 and Bowtie2 were then merged by using the 
Picard command SamMerge.
Transcript assembly with Cufflinks: the merged 
reads were processed with Cufflinks. Cufflinks normalizes 
the RNA-Seq fragment counts to estimate the abundance 
of each transcript. Abundance was measured in the units 
of fragments per kilobase of exon per million fragments 
mapped (FPKM). For this analysis the same GTF 
annotation file used for Tophat2 was used to guide the 
assembly. The graphical representation of expression 
value was generated by using RNASeqViewer V. 0.8.0.
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